Journal
GENES
Volume 13, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/genes13010123
Keywords
variant of unknown significance; VUS; whole exome sequencing; thoracic aortic aneurysm; zebrafish; EMILIN1; MIB1
Categories
Funding
- Aortic Institute at Yale-New Haven
Ask authors/readers for more resources
This study demonstrates the potential of using zebrafish mutants to assess candidate genes for pathogenicity in patients with thoracic aortic aneurysm. Various pathogenic mutations were found to cause abnormalities in the heart, brain, aorta, and skeleton. Using zebrafish models could provide a rapid and evidence-based approach to evaluating the significance of genetic variants identified in clinical practice.
(1) Background: Whole Exome Sequencing of patients with thoracic aortic aneurysm often identifies Variants of Uncertain Significance (VUS), leading to uncertainty in clinical management. We assess a novel mechanism for potential routine assessment of these genes in TAA patients. Zebrafish are increasingly used as experimental models of disease. Advantages include low cost, rapid maturation, and physical transparency, permitting direct microscopic assessment. (2) Methods: Zebrafish loss of function mutations were generated using a CRISPRC/CAS9 approach for EMILIN1 and MIB1 genes similar to VUSs identified in clinical testing. Additionally, positive control mutants were constructed for known deleterious variants in FBN1 (Marfan's) and COL1A2, COL5A1, COL5A2 (Ehlers-Danlos). Zebrafish embryos were followed to six days post-fertilization. Embryos were studied by brightfield and confocal microscopy to ascertain any vascular, cardiac, and skeletal abnormalities. (3) Results: A dramatic pattern of cardiac, cerebral, aortic, and skeletal abnormalities was identified for the known pathogenic FBN1 and COL1A2, COL5A1, and COL5A2 mutants, as well as for the EMILIN1 and MIB1 mutants of prior unknown significance. Visualized abnormalities included hemorrhage (peri-aortic and cranial), cardiomegaly, reduced diameter of the aorta and intersegmental vessels, lower aortic cell counts, and scoliosis (often extremely severe). (4) Conclusion: This pilot study suggests that candidate genes arising in clinical practice may be rapidly assessed via zebrafish mutants-thus permitting evidence-based decisions about pathogenicity. Thus, years-long delays to clinically demonstrate pathogenicity may be obviated. Zebrafish data would represent only one segment of analysis, which would also include frequency of the variant in the general population, in silico genetic analysis, and degree of preservation in phylogeny.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available